SCHEMBL14343189

SCHEMBL14343189

Nc1ccc2c(c1)ncc1cc(Oc3ccc4c(c3)Cc3cc(Oc5ccc6c(cnc7cc(N)ccc76)c5)ccc3-4)ccc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.38
▸ LMNA P02545 4/20 0.38
▸ ALDH1A1 P00352 4/20 0.38
▸ KDM4E B2RXH2 3/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ PDPK1 O15530 1/20 0.38
▸ MEN1 O00255 4/20 0.34
▸ KMT2A Q03164 4/20 0.34
▸ ACHE P22303 2/20 0.34
▸ TERT O14746 1/20 0.34
▸ ABCB11 O95342 1/20 0.34
▸ THRB P10828 1/20 0.34
▸ BLM P54132 1/20 0.34
▸ GPR55 Q9Y2T6 1/20 0.34
▸ TLR9 Q9NR96 2/20 0.33
▸ APP P05067 1/20 0.33
▸ HTT P42858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14342924 0.95 MAPT (0.38) MAPTLMNAALDH1A1KDM4ERAB9A
SCHEMBL15092880 0.81 PDPK1 (0.33) MAPTLMNAALDH1A1KDM4EHPGD
SCHEMBL14343201 0.79 ALDH1A1 (0.50) MAPTLMNAALDH1A1KDM4ERAB9A
SCHEMBL15093342 0.77 NSD2 (0.32) PDPK1
SCHEMBL14342967 0.77 ALDH1A1 (0.60) MAPTLMNAALDH1A1KDM4ERAB9A
SCHEMBL14342988 0.76 ALDH1A1 (0.47) MAPTLMNAALDH1A1KDM4ERAB9A
SCHEMBL9207870 0.75 TLR9 (0.47) MAPTLMNAALDH1A1KDM4ERAB9A
SCHEMBL14342956 0.75 KMT2A (0.49) MAPTLMNAALDH1A1KDM4ERAB9A
SCHEMBL14343044 0.74 ALDH1A1 (0.56) MAPTLMNAALDH1A1KDM4ERAB9A
SCHEMBL14343002 0.74 ALDH1A1 (0.56) MAPTLMNAALDH1A1KDM4ERAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2692775-B1 POLYIMIDE, POLYIMIDE-BASED POLYMER ELECTROLYTE MEMBRANE, MEMBRANE- ELECTRODE ASSEMBLY, AND POLYMER ELECTROLYTE FUEL CELL NITTO DENKO CORP (JP) 2015-04-08 — — EP disclosed
US-20140235896-A1 NOVEL DIAMINE COMPOUND NITTO DENKO CORPORATION (JP) 2014-08-21 — — US disclosed
US-8748664-B2 Diamine compound and production method thereof NITTO DENKO CORPORATION (JP) 2014-06-10 — — US disclosed
EP-2692775-A1 POLYIMIDE, POLYIMIDE POLYMER ELECTROLYTE MEMBRANE, MEMBRANE ELECTRODE ASSEMBLY, AND SOLID POLYMER FUEL CELL Nitto Denko Corporation (JP) 2014-02-05 — — EP disclosed
US-20130171541-A1 POLYIMIDE, POLYIMIDE-BASED POLYMER ELECTROLYTE MEMBRANE, MEMBRANE-ELECTRODE ASSEMBLY, AND POLYMER ELECTROLYTE FUEL CELL NITTO DENKO CORPORATION (JP) 2013-07-04 — — US disclosed
US-20130006017-A1 NOVEL DIAMINE COMPOUND AND PRODUCTION METHOD THEREOF NITTO DENKO CORPORATION (JP) 2013-01-03 — — US disclosed
EP-2540699-A1 NOVEL DIAMINE COMPOUND AND PRODUCTION METHOD THEREOF Nitto Denko Corporation (JP) 2013-01-02 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130006017-A1 NOVEL DIAMINE COMPOUND AND PRODUCTION METHOD THEREOF AOC1, SAT1, ODC1 MAPT 2105/4885LMNA 2654/4885ALDH1A1 100/4885
US-20140235896-A1 NOVEL DIAMINE COMPOUND AOC1, SAT1, ARG1 MAPT 2060/4885LMNA 2652/4885ALDH1A1 55/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback